BRCA1 and neoplasm: Loss of heterozygosity at the BRCA1 locus has been reported in 20%–70% of sporadic breast and ovarian cases [10]–[14] and in breast cancers has been correlated with larger tumor size, higher grade, and negative hormone receptor negative status [15].